Evidence map›Paper›PMID 30212499›Full record

ArticlePloS one2018

A Bayesian framework for efficient and accurate variant prediction.

Dajun Qian, Shuwei Li, Yuan Tian, Jacob W Clifford, Brice A J Sarver, Tina Pesaran, Chia-Ling Gau, Aaron M Elliott, Hsiao-Mei Lu, Mary Helen Black

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus.bioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Variation benchmark datasets: update, criteria, quality and applications.Database : the journal of biological databases and curation · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dajun QianAmbry Genetics, Aliso Viejo, California, United States of America.ORCID 0000-0002-5527-4856
Shuwei LiAmbry Genetics, Aliso Viejo, California, United States of America.ORCID 0000-0001-7176-1964
Yuan TianAmbry Genetics, Aliso Viejo, California, United States of America.
Jacob W CliffordAmbry Genetics, Aliso Viejo, California, United States of America.ORCID 0000-0002-3599-0249
Brice A J SarverAmbry Genetics, Aliso Viejo, California, United States of America.
Tina PesaranAmbry Genetics, Aliso Viejo, California, United States of America.
Chia-Ling GauAmbry Genetics, Aliso Viejo, California, United States of America.
Aaron M ElliottAmbry Genetics, Aliso Viejo, California, United States of America.
Hsiao-Mei LuAmbry Genetics, Aliso Viejo, California, United States of America.
Mary Helen BlackAmbry Genetics, Aliso Viejo, California, United States of America.ORCID 0000-0002-1654-0234

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing need to develop variant prediction tools capable of assessing a wide spectrum of evidence. We present a Bayesian framework that involves aggregating pathogenicity data across multiple in silico scores on a gene-by-gene basis and multiple evidence statistics in both quantitative and qualitative forms, and performs 5-tiered variant classification based on the resulting probability credible interval. When evaluated in 1,161 missense variants, our gene-specific in silico model-based meta-predictor yielded an area under the curve (AUC) of 96.0% and outperformed all other in silico predictors. Multifactorial model analysis incorporating all available evidence yielded 99.7% AUC, with 22.8% predicted as variants of uncertain significance (VUS). Use of only 3 auto-computed evidence statistics yielded 98.6% AUC with 56.0% predicted as VUS, which represented sufficient accuracy to rapidly assign a significant portion of VUS to clinically meaningful classifications. Collectively, our findings support the use of this framework to conduct large-scale variant prioritization using in silico predictors followed by variant prediction and classification with a high degree of predictive accuracy.

Indexed as

Bayes TheoremArea Under CurveGenetic Predisposition to DiseaseGenetic TestingMutation, Missense

Identifiers

PMID30212499
PMCPMC6136750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.